Key considerations for the clinical management of rapidly progressing ADPKD
After watching this activity, participants should be better able to:
- Recognize how to predict progression in patients with autosomal dominant polycystic kidney disease (ADPKD)
- Discuss the efficacy data for the currently available and emerging pharmacological treatment options for rapidly progressing ADPKD
- Discuss how to manage key side effects when using vasopressin V2 receptor antagonists in ADPKD
In this activity, a radiologist, a nephrologist and a primary care physician discuss how to predict disease progression and prognosis in ADPKD, as well as current and emerging treatment options for rapidly progressing disease and how to manage potential
treatment-related side effects. The discussion is guided by pre-canvassed questions provided by healthcare professionals involved in the management of patients with ADPKD.
This activity is jointly provided by USF Health and touchIME. read more
This activity has been designed to meet the educational needs of endocrinologists, nephrologists, renal pharmacists, primary care physicians and radiologists involved in the management of ADPKD.
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
Prof. Bradley Erickson has no interests/relationships or affiliations to disclose in relation to
Prof. Neera Dahl discloses: Advisory board or panel fees from Natera. Consultancy fees from Otsuka and Vertex. Grants/research support from Reata Pharmaceuticals. Speaker’s bureau fees from Otsuka.
Prof. Charles Vega discloses: Consultancy fees from Boehringer Ingelheim, GlaxosmithKline and Johnson & Johnson.
Kevin Cowart, PharmD, MPH, BCACP, CDCES has no financial interests/relationships or affiliations in relation to this activity.
Touch Medical Director
Katrina Lester has no financial interests/relationships or affiliations in relation to this activity.
USF Health Office of Continuing Professional Development and touchIME staff have no financial interests/relationships or affiliations in relation to this activity.
Requirements for Successful Completion
In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.
If you have questions regarding credit please contact email@example.com
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and touchIME. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The European Union of Medical Specialists (UEMS) – European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu)
Advanced Practice Providers
Physician Assistants may claim a maximum of 0.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
The AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM by ACCME-accredited providers. APRNs who participate will receive a certificate of completion commensurate with the extent of their participation.
USF Health is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based program has been approved for 0.75 contact hours (0.75 CEUs). Universal program number is as follows: 0230-9999-23-004-H01-P.
Date of original release: 29 March 2023. Date credits expire: 29 March 2024.
If you have any questions regarding credit please contact firstname.lastname@example.org
To obtain contact hours from this activity, please complete this post-activity test.Claim Credit
You may also be interested in...
Key considerations for the clinical management of rapidly progressing ADPKDThis activity is CE/CME accredited
Addressing cardiorenal outcomes in CKD and T2D: What are the key considerations for daily practice?This activity is CE/CME accredited
Sara (Mandy) Reece, ADCES 2022: Chronic kidney disease in type 2 diabetes: An update for the diabetes care and education specialist
Hiddo Heerspink, ADA 2022: Tirzepatide in SURPASS-4 for chronic kidney disease in patients with type 2 diabetes
Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
Hyperinsulinaemic Hypoglycaemia and Polycystic Kidney Disease – A Rare Case Concerning PMM2 Gene Pleiotropy
REGISTER NOW FOR FREE ACCESS TO
- 1000+ topical and insightful peer-reviewed journal articles
- 100+ hours of bite-sized congress highlights
- 8 major therapy areas packed with the latest scientific advances
- 150+ specialties offering learn-on-the-go medical education
- + Concise email updates and newsletters so you never miss out
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!